AstraZeneca and Oracle announced a partnership. They will use artificial intelligence and real-world data to improve clinical trial efficiency. The collaboration combines Oracle's health data, cloud, and AI capabilities with AstraZeneca's scientific expertise. This aims to accelerate clinical research and enhance patient care.
The partnership aims to overcome major obstacles in drug development. This includes patient recruitment. It will identify eligible candidates for trials more efficiently.
The partnership will initially explore applications in oncology, cardiovascular diseases, and rare diseases. This initiative will connect scientific research more directly with clinical workflows. The goal is to speed up the delivery of new medicines to patients.